InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Stonehouse Jon P, Chairman & CEO. Director active across 2 companies, notably Biocryst Pharmaceuticals INC. Cumulatively, 6 disclosures have been published. The latest transaction was filed on 11 January 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€768,127184,000 shares@ €4.17460.046% mcap100.0% of flow
Common Stock
SEC:0001127602-22-001458·
€768,127184,000 shares@ €4.17460.046% mcap50.0% of flow
Common Stock
SEC:0001127602-22-001458:0·
021,504 shares0
Common Stock
SEC:0001628280-22-000413·
021,504 shares0
Common Stock
SEC:0001628280-22-000413:0·
05,000 shares0
Common Stock
SEC:0001127602-21-031116·
05,000 shares0
Common Stock
SEC:0001127602-21-031116:0·
6 of 6 declarations
About Stonehouse Jon P
Jon P. Stonehouse is President & CEO and Director at Biocryst Pharmaceuticals Inc. As the leader of the company, he is responsible for strategic direction and management of operations. His experience in the pharmaceutical sector is an asset for Biocryst.
